Kai‐Ping Chang

10.0k total citations · 1 hit paper
270 papers, 6.8k citations indexed

About

Kai‐Ping Chang is a scholar working on Surgery, Otorhinolaryngology and Oncology. According to data from OpenAlex, Kai‐Ping Chang has authored 270 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Surgery, 90 papers in Otorhinolaryngology and 90 papers in Oncology. Recurrent topics in Kai‐Ping Chang's work include Head and Neck Cancer Studies (84 papers), Salivary Gland Tumors Diagnosis and Treatment (28 papers) and Head and Neck Surgical Oncology (27 papers). Kai‐Ping Chang is often cited by papers focused on Head and Neck Cancer Studies (84 papers), Salivary Gland Tumors Diagnosis and Treatment (28 papers) and Head and Neck Surgical Oncology (27 papers). Kai‐Ping Chang collaborates with scholars based in Taiwan, United States and China. Kai‐Ping Chang's co-authors include Yu‐Sun Chang, Sheng‐Po Hao, Jau‐Song Yu, Huang‐Kai Kao, Ngan‐Ming Tsang, Chih‐Ching Wu, Tai‐Tong Wong, Ying Liang, Chia‐Wei Hsu and Chuen Hsueh and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Kai‐Ping Chang

262 papers receiving 6.7k citations

Hit Papers

Oral Microbiota Community... 2018 2026 2020 2023 2018 50 100 150 200 250

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kai‐Ping Chang 2.2k 2.0k 1.7k 1.7k 1.2k 270 6.8k
Ricardo D. Coletta 3.8k 1.7× 1.9k 1.0× 1.2k 0.7× 1.1k 0.6× 1.8k 1.5× 319 8.0k
Wendell G. Yarbrough 4.0k 1.8× 3.5k 1.7× 1.8k 1.0× 2.7k 1.6× 1.5k 1.3× 196 8.7k
Ziv Gil 1.4k 0.6× 2.0k 1.0× 3.2k 1.8× 1.9k 1.1× 929 0.8× 169 6.9k
Andrew G. Sikora 1.6k 0.7× 2.7k 1.4× 1.6k 0.9× 1.6k 0.9× 637 0.6× 178 6.9k
Jens Peter Klußmann 1.2k 0.5× 3.0k 1.5× 3.2k 1.9× 3.6k 2.2× 996 0.9× 285 7.3k
Richard J. Wong 1.7k 0.8× 3.6k 1.8× 3.8k 2.2× 3.3k 2.0× 662 0.6× 293 10.3k
Oreste Gallo 943 0.4× 1.7k 0.9× 1.7k 1.0× 1.3k 0.8× 665 0.6× 183 4.7k
Theodoros N. Teknos 2.6k 1.2× 3.5k 1.8× 4.1k 2.3× 4.5k 2.7× 1.6k 1.3× 231 10.9k
Susan Müller 1.1k 0.5× 1.3k 0.7× 1.2k 0.7× 818 0.5× 325 0.3× 117 4.5k
William K. Funkhouser 1.9k 0.9× 1.6k 0.8× 777 0.4× 584 0.4× 1.2k 1.0× 104 4.7k

Countries citing papers authored by Kai‐Ping Chang

Since Specialization
Citations

This map shows the geographic impact of Kai‐Ping Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Ping Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Ping Chang more than expected).

Fields of papers citing papers by Kai‐Ping Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Ping Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Ping Chang. The network helps show where Kai‐Ping Chang may publish in the future.

Co-authorship network of co-authors of Kai‐Ping Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Ping Chang. A scholar is included among the top collaborators of Kai‐Ping Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Ping Chang. Kai‐Ping Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yehuan, et al.. (2025). Clinical Application of Monitoring Vital Signs in Dogs Through Ballistocardiography (BCG). Veterinary Sciences. 12(4). 301–301.
2.
Huang, Yenlin, Anna See, Johnny Chuieng‐Yi Lu, et al.. (2024). Postoperative radiotherapy versus surgery alone in pN1 oral cavity cancer patients: A meta‐analysis. Laryngoscope Investigative Otolaryngology. 9(3). e1260–e1260. 1 indexed citations
3.
Tsai, Hui‐Ju, Huiwen Chen, Ian Yi‐Feng Chang, et al.. (2024). Noncanonical formation of SNX5 gene-derived circular RNA regulates cancer growth. Cell Death and Disease. 15(8). 599–599. 1 indexed citations
4.
5.
Li, Hsin‐Pai, Chen‐Yang Huang, Kar‐Wai Lui, et al.. (2023). Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways. Translational Oncology. 38. 101785–101785. 3 indexed citations
6.
Lee, Yi‐Chan, Li‐Yu Lee, Yenlin Huang, et al.. (2023). Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer. Laryngoscope Investigative Otolaryngology. 8(6). 1547–1556. 2 indexed citations
7.
Liu, Hsuan, Yuhao Liu, Chih‐Ching Wu, et al.. (2022). Modular scaffolding by lncRNA HOXA10-AS promotes oral cancer progression. Cell Death and Disease. 13(7). 629–629. 12 indexed citations
8.
9.
Lee, Li‐Ang, Tuan‐Jen Fang, Hsueh‐Yu Li, et al.. (2021). Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan. Cancers. 13(7). 1741–1741. 10 indexed citations
10.
Chou, Yung‐Chih, Kang‐Hsing Fan, Chien‐Yu Lin, et al.. (2021). Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study. Cancers. 13(14). 3555–3555. 21 indexed citations
11.
Yang, Chia‐Yu, Ian Yi‐Feng Chang, Chun‐Nan OuYang, et al.. (2020). Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts. Cancers. 12(7). 1726–1726. 17 indexed citations
12.
Ho, Tsung‐Ying, Kai‐Ping Chang, Wen‐Chi Chou, et al.. (2020). Prognostic significance of the preoperative systemic immune‐inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy. Cancer Medicine. 10(2). 649–658. 14 indexed citations
13.
Chang, Ya‐Ting, Lichieh Julie Chu, Yen‐Chun Liu, et al.. (2020). Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer. Cancers. 12(8). 2273–2273. 34 indexed citations
14.
Chang, Ian Yi‐Feng, Yuhao Liu, Hsuan Liu, et al.. (2020). circRNAome Profiling in Oral Carcinoma Unveils a Novel circFLNB that Mediates Tumour Growth-Regulating Transcriptional Response. Cells. 9(8). 1868–1868. 2 indexed citations
15.
Lin, Yen‐Heng, Weiting Su, Pei‐Chi Tseng, et al.. (2020). Target peptide enrichment microfluidic chip for rapid detection of oral squamous cell carcinoma using stable isotope standards and capture by anti-peptide antibodies. Sensors and Actuators B Chemical. 322. 128607–128607. 9 indexed citations
16.
Hsiao, Yen-Chang, Kun‐Yi Chien, Ya‐Ting Chang, et al.. (2019). An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples. Analytica Chimica Acta. 1100. 118–130. 30 indexed citations
17.
Hsu, Kuo‐Yao, Yun‐Fang Tsai, Wen‐Ling Yeh, et al.. (2018). Tobacco-Smoking, Alcohol-Drinking, and Betel-Quid-Chewing Behaviors: Development and Use of a Web-Based Survey System. JMIR mhealth and uhealth. 6(6). e142–e142. 14 indexed citations
18.
Wu, Chih‐Ching, Ya‐Ting Chang, Kai‐Ping Chang, et al.. (2014). Salivary Auto-Antibodies as Noninvasive Diagnostic Markers of Oral Cavity Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 23(8). 1569–1578. 23 indexed citations
19.
Chang, Kai‐Ping, Sheng‐Po Hao, Chih‐Ching Wu, et al.. (2008). Macrophage Inflammatory Protein-3α Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes. Clinical Cancer Research. 14(21). 6979–6987. 57 indexed citations
20.
Tse, Ka‐Po, Hsin‐Pai Li, Ying Liang, et al.. (2007). MCP-1 Promoter Polymorphism at −2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment. Clinical Cancer Research. 13(21). 6320–6326. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026